• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

NephroGenex Inc

+ Add to Watchlist


5.4500 USD 0.00000.00%

As of 20:10:00 ET on 07/11/2014.

Snapshot for NephroGenex Inc (NRX)

Open: 5.4500 Day's Range: 5.3001 - 5.4609 Volume: 2,550
Previous Close: 5.4500 52wk Range: 5.0000 - 13.0000 1-Yr Rtn: -

Stock Chart for NRX

No chart data available.
  • NRX:US 5.4500
  • 1D
  • 1M
  • 1Y
Interactive NRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.2600
Est. PEG Ratio -
Market Cap (M USD) 46.63
Shares Outstanding (M) 8.56
30 Day Average Volume 14,603
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NRX

No data available

Company Profile & Key Executives for NRX

NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients.

Pierre LegaultChief Executive OfficerJ Wesley FoxPres/Chief Scientific Officer
John P HamillCFO/Treasurer/SecretaryBob PetersonVP:Product Dev
More Company Profile & Key Executives for NRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil